28 algorithm-development-"Prof"-"Prof" Postdoctoral positions at Carnegie Mellon University
Sort by
Refine Your Search
-
addresses important problems in technology and policy. We educate technically skilled students to be leaders in policy-focused research; we work on policy problems in which the technology matters
-
in the development and execution of research projects related to cloning, experimental automation and DNA experiment design and such other tasks that are assigned to you. Core Responsibilities: Leads
-
in the development and execution of research projects related to cloning, experimental automation and DNA experiment design and such other tasks that are assigned to you. Core Responsibilities: Leads
-
research and educate the next generation of security and privacy professionals. Everything we do is fueled by our passion to create a world in which technology can be trusted. CyLab is seeking a Postdoctoral
-
research and educate the next generation of security and privacy professionals. Everything we do is fueled by our passion to create a world in which technology can be trusted. CyLab is seeking a Postdoctoral
-
curious to deliver work that matters, your journey starts here! The Civil and Environmental Engineering Department at Carnegie Mellon offers a unique interdisciplinary program that enables you to develop
-
cells and determining the effect of growth conditions and environmental stressors on function, as well as developing and testing reporter assays. In addition, you will be involved in a larger
-
or within specific applications; developing innovative machine learning methods to analyze complex societal systems; investigating the societal effects of AI and machine learning. This position provides
-
on developing a microfluidic technology for loading molecules and nanoparticles into red blood cells ex vivo, with the goal of leveraging red blood cells as a biocompatible drug depot for extended release. The
-
on developing a microfluidic technology for loading molecules and nanoparticles into red blood cells ex vivo, with the goal of leveraging red blood cells as a biocompatible drug depot for extended release. The